cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.9070
+0.0330 (3.78%)
Jun 27, 2025, 4:00 PM - Market closed
cbdMD Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2018 - 2019 |
| 19.59 | 19.48 | 24.16 | 35.4 | 44.48 | 41.88 | Upgrade
| |
Revenue Growth (YoY) | -9.22% | -19.35% | -31.77% | -20.41% | 6.20% | 77.09% | Upgrade
|
Cost of Revenue | 7.38 | 7.49 | 9.18 | 13.07 | 14.5 | 15.51 | Upgrade
|
Gross Profit | 12.22 | 12 | 14.98 | 22.34 | 29.99 | 26.37 | Upgrade
|
Selling, General & Admin | 11.97 | 13.27 | 18.93 | 33.29 | 43.37 | 38.83 | Upgrade
|
Research & Development | 0.04 | 0.04 | 0.17 | 0.63 | 1.42 | 0.42 | Upgrade
|
Other Operating Expenses | 0.32 | 0.86 | 3.34 | 3.89 | 3.79 | 3.97 | Upgrade
|
Operating Expenses | 13.49 | 15.31 | 24.25 | 39.65 | 49.6 | 43.95 | Upgrade
|
Operating Income | -1.27 | -3.32 | -9.27 | -17.31 | -19.62 | -17.58 | Upgrade
|
Interest Expense | -0.01 | -0.03 | - | - | -0.03 | - | Upgrade
|
Interest & Investment Income | 0.02 | - | 0.06 | 0.02 | - | 0.04 | Upgrade
|
Other Non Operating Income (Expenses) | - | - | - | 0.24 | 0.03 | - | Upgrade
|
EBT Excluding Unusual Items | -1.26 | -3.34 | -9.2 | -17.06 | -19.62 | -17.54 | Upgrade
|
Merger & Restructuring Charges | - | - | - | -0.6 | - | - | Upgrade
|
Impairment of Goodwill | - | - | - | -56.67 | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | -0.7 | -0.03 | 0.55 | -0.93 | Upgrade
|
Gain (Loss) on Sale of Assets | - | - | - | 0.09 | - | - | Upgrade
|
Asset Writedown | - | - | -13.22 | -4.29 | - | - | Upgrade
|
Other Unusual Items | 1.1 | -0.36 | 0.19 | 8.47 | -5.22 | 29.78 | Upgrade
|
Pretax Income | -0.16 | -3.7 | -22.94 | -70.08 | -24.29 | 11.31 | Upgrade
|
Income Tax Expense | - | - | - | - | -0.9 | -1.35 | Upgrade
|
Earnings From Continuing Operations | -0.16 | -3.7 | -22.94 | -70.08 | -23.39 | 12.65 | Upgrade
|
Earnings From Discontinued Operations | - | - | - | - | - | -0.05 | Upgrade
|
Net Income | -0.16 | -3.7 | -22.94 | -70.08 | -23.39 | 12.6 | Upgrade
|
Preferred Dividends & Other Adjustments | 4 | 4 | 4 | 4 | 2.55 | 0.37 | Upgrade
|
Net Income to Common | -4.16 | -7.7 | -26.94 | -74.09 | -25.95 | 12.24 | Upgrade
|
Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | 0 | Upgrade
|
Shares Change (YoY) | 95.06% | 113.25% | 52.31% | 8.76% | 21.62% | 152.53% | Upgrade
|
EPS (Basic) | -6.03 | -14.29 | -106.57 | -446.37 | -170.04 | 99.79 | Upgrade
|
EPS (Diluted) | -6.05 | -14.32 | -106.57 | -446.40 | -170.04 | 99.79 | Upgrade
|
Free Cash Flow | -0.24 | -0.54 | -4.6 | -15.66 | -14.44 | -11.98 | Upgrade
|
Free Cash Flow Per Share | -0.35 | -1.01 | -18.20 | -94.33 | -94.59 | -95.51 | Upgrade
|
Gross Margin | 62.36% | 61.57% | 62.01% | 63.09% | 67.41% | 62.96% | Upgrade
|
Operating Margin | -6.49% | -17.02% | -38.37% | -48.89% | -44.10% | -41.98% | Upgrade
|
Profit Margin | -21.25% | -39.55% | -111.53% | -209.26% | -58.34% | 29.21% | Upgrade
|
Free Cash Flow Margin | -1.23% | -2.79% | -19.04% | -44.22% | -32.45% | -28.61% | Upgrade
|
EBITDA | -0.11 | -2.17 | -7.47 | -15.48 | -18.6 | -16.86 | Upgrade
|
EBITDA Margin | -0.57% | -11.12% | -30.92% | -43.72% | -41.81% | -40.26% | Upgrade
|
D&A For EBITDA | 1.16 | 1.15 | 1.8 | 1.83 | 1.02 | 0.72 | Upgrade
|
EBIT | -1.27 | -3.32 | -9.27 | -17.31 | -19.62 | -17.58 | Upgrade
|
EBIT Margin | -6.49% | -17.02% | -38.37% | -48.89% | -44.10% | -41.98% | Upgrade
|
Revenue as Reported | 19.59 | 19.48 | 24.16 | 35.4 | 44.48 | 41.88 | Upgrade
|
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.